The statistical software revolution in pharmaceutical development: challenges and opportunities in open source
- DOI
- 10.1016/j.drudis.2026.104613
- Published
- 2026-03
- Container
- Drug Discovery Today
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.drudis.2026.104613,
title = {The statistical software revolution in pharmaceutical development: challenges and opportunities in open source},
author = {Daniel Sabanés Bové and Heidi Seibold and Anne-Laure Boulesteix and Juliane Manitz and Alessandro Gasparini and Burak K. Günhan and Oliver Boix and Armin Schüler and Sven Fillinger and Sven Nahnsen and Anna E. Jacob and Thomas Jaki},
year = {2026},
journal = {Drug Discovery Today},
doi = {10.1016/j.drudis.2026.104613},
url = {https://doi.org/10.1016/j.drudis.2026.104613}
}RIS
TY - JOUR TI - The statistical software revolution in pharmaceutical development: challenges and opportunities in open source AU - Daniel Sabanés Bové AU - Heidi Seibold AU - Anne-Laure Boulesteix AU - Juliane Manitz AU - Alessandro Gasparini AU - Burak K. Günhan AU - Oliver Boix AU - Armin Schüler AU - Sven Fillinger AU - Sven Nahnsen AU - Anna E. Jacob AU - Thomas Jaki PY - 2026 JO - Drug Discovery Today DO - 10.1016/j.drudis.2026.104613 UR - https://doi.org/10.1016/j.drudis.2026.104613 ER -
APA
Bové, D. S., Seibold, H., Boulesteix, A., Manitz, J., Gasparini, A., Günhan, B. K., Boix, O., Schüler, A., Fillinger, S., Nahnsen, S., Jacob, A. E., & Jaki, T. (2026). The statistical software revolution in pharmaceutical development: challenges and opportunities in open source. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2026.104613
Source records
- crossref · retrieved 2026-09-25T10:55:03.935Z